Misfolding and aggregation of amyloid peptides into β‐structure‐rich fibrils represent pivotal
pathological features in various neurodegenerative diseases, including Alzheimer's disease …

Misfolding and aggregation of amyloid peptides are critical pathological events in numerous
protein misfolding diseases (PMDs), such as Alzheimer's disease (AD), type II diabetes …

Abstract Development of a rapid and sensitive method for Aβ (1-42) aggregation detection is
of great importance to overcome the limitations of conventional techniques. In this study, we …

A nanoparticle-based assay utilizing time-resolved luminescence resonance energy transfer
(TR-LRET) was developed for the detection of β-amyloid aggregation. The assay is based …

Advances in diagnostic medicine have led to an increased awareness and heightened
concern for the high prevalence of amyloid-associated neurodegenerative diseases …

A major challenge in the Alzheimer's disease (AD) is its timely diagnosis. Amyloid β (Aβ)
aggregates have been proposed as the most viable biomarker for the diagnosis of AD. Here …

Amyloid self-assembly is pathologically linked to many neurodegenerative diseases,
including Alzheimer's disease (AD) and Parkinson's disease (PD). While many inhibitors …

Alzheimer's disease (AD) is a neurodegenerative disorder that severely jeopardizes the
health of aging populations all over the world. According to the amyloid cascade hypothesis …

Amyloid plaques generated from the accumulation of amyloid-β peptides (Aβ) fibrils in the
brain is one of the main hallmarks of Alzheimer's disease (AD), a most common …

Evidence indicated that shifting treatment to a presymptomatic stage may produce significant
benefits to prevent/alleviate the progression of Alzheimer's disease (AD); in particular, early …